Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Organigram Global ( (TSE:OGI) ) just unveiled an update.
Organigram Global shareholders have overwhelmingly approved the acquisition of Germany-based Sanity Group GmbH and a related private placement with a British American Tobacco subsidiary, clearing a key hurdle for the all-share deal. The transaction, which still requires customary closing conditions and is expected to close in April 2026, will see Organigram issue up to 96.3 million new common shares to Sanity Group investors and BAT.
The acquisition is positioned as financially accretive, adding a profitable asset and giving Organigram a vertically integrated European hub with local leadership, strategic partnerships and regulatory know-how. The deal is set to solidify Organigram’s status as a leader in the global cannabis market by pairing its top-ranked Canadian adult-use franchise with a strong foothold in Germany’s fast-growing medical cannabis sector, while board continuity was confirmed as shareholders re-elected all ten director nominees.
The most recent analyst rating on (TSE:OGI) stock is a Hold with a C$2.00 price target. To see the full list of analyst forecasts on Organigram Global stock, see the TSE:OGI Stock Forecast page.
Spark’s Take on OGI Stock
According to Spark, TipRanks’ AI Analyst, OGI is a Neutral.
The score is held back most by weak underlying profitability/cash flow and bearish technicals (below key moving averages with negative MACD). Offsetting these are a strong low-leverage balance sheet, a low P/E valuation, and a generally positive earnings call with reiterated full-year guidance and improving operational metrics.
To see Spark’s full report on OGI stock, click here.
More about Organigram Global
Organigram Global Inc. is a cannabis producer focused on the Canadian adult-use recreational market, where it holds a leading share. Through strategic partnerships and international expansion, the company is also building a presence in emerging global medical cannabis markets, including Europe, to leverage its brands, product innovation and regulatory expertise.
Average Trading Volume: 236,758
Technical Sentiment Signal: Sell
Current Market Cap: C$246.8M
For a thorough assessment of OGI stock, go to TipRanks’ Stock Analysis page.